BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 34399947)

  • 1. Transgender men: clinical care and implications in reproductive medicine: introduction.
    de Ziegler D; de Sutter P
    Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uterus in transgender men.
    Carbonnel M; Karpel L; Cordier B; Pirtea P; Ayoubi JM
    Fertil Steril; 2021 Oct; 116(4):931-935. PubMed ID: 34364678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masculinizing gender-affirming surgery for trans men and non-binary individuals: what you should know.
    Patel DP; Goodwin IA; Acar O; Kocjancic E; Hotaling JM
    Fertil Steril; 2021 Oct; 116(4):924-930. PubMed ID: 34404544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
    Lierman S; Tolpe A; De Croo I; De Gheselle S; Defreyne J; Baetens M; Dheedene A; Colman R; Menten B; T'Sjoen G; De Sutter P; Tilleman K
    Fertil Steril; 2021 Oct; 116(4):1068-1076. PubMed ID: 33832736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicolegal issues surrounding legal sex designations.
    Shteyler VM; Adashi EY
    Fertil Steril; 2021 Oct; 116(4):922-923. PubMed ID: 34579827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Gender-Affirming Treatment for the Transgender Woman.
    Unger CA
    Semin Reprod Med; 2017 Sep; 35(5):442-447. PubMed ID: 29073683
    [No Abstract]   [Full Text] [Related]  

  • 8. Does Testosterone Treatment Increase Anger Expression in a Population of Transgender Men?
    Motta G; Crespi C; Mineccia V; Brustio PR; Manieri C; Lanfranco F
    J Sex Med; 2018 Jan; 15(1):94-101. PubMed ID: 29175227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transgender, transsexualism and gender dysphoria: current developments in diagnostics and health care].
    Nieder TO; Briken P; Richter-Appelt H
    Psychother Psychosom Med Psychol; 2014 Jun; 64(6):232-45. PubMed ID: 24892869
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disaffirming Gender: Somatic Incongruence as a Co-function of Ideological Congruity.
    Olver T
    Psychoanal Rev; 2019 Feb; 106(1):1-28. PubMed ID: 30730258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-affirming hormones and surgery in transgender children and adolescents.
    Mahfouda S; Moore JK; Siafarikas A; Hewitt T; Ganti U; Lin A; Zepf FD
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term clinical skin effects of testosterone treatment in trans men.
    Wierckx K; Van de Peer F; Verhaeghe E; Dedecker D; Van Caenegem E; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Jan; 11(1):222-9. PubMed ID: 24344810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing normality-persisting barriers: Current socio-demographic characteristics of 350 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Herrmann E; Bojunga J
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):241-246. PubMed ID: 31821578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
    Aubrey C; Saad N; Köbel M; Mattatall F; Nelson G; Glaze S
    Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Concepts in Feminizing Gender Surgery.
    Safa B; Lin WC; Salim AM; Deschamps-Braly JC; Poh MM
    Plast Reconstr Surg; 2019 May; 143(5):1081e-1091e. PubMed ID: 31033837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring Gender-Affirming Care in Nephrology: Improving Care for Transgender and Gender-Expansive Individuals.
    Mohottige D; Lunn MR
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1195-1197. PubMed ID: 32139362
    [No Abstract]   [Full Text] [Related]  

  • 19. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
    Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
    Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-Affirming Hormone Therapy for Transgender Men.
    Moravek MB
    Clin Obstet Gynecol; 2018 Dec; 61(4):687-704. PubMed ID: 30285972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.